RT @EU_Health: 66% of 🇪🇺 citizens believe we need greater EU involvement to step up the fight against health crises.
Register for our #EUHealthSecurity event today & join the discussions on building a strong #HealthUnion.
Register today 👉https://www.cll-conference.eu/
RT @EFSA_EU: 💻Registrations are open for the EU AI Talk
The aim is to reflect on the importance & potential of #ArtificialIntelligence within the 🇪🇺 & more specifically with regard to the public sector & the EU Agencies
📅30/11/22 | Live edition
⏰23/11/22
📒More: https://www.efsa.europa.eu/en/events/eu-ai-talk-live-edition
RT @Eurosurveillanc: Now 𝘌𝘶𝘳𝘰𝘴𝘶𝘳𝘷𝘦𝘪𝘭𝘭𝘢𝘯𝘤𝘦 readers get an overview of the public health impact of #Outbreak reports, #Surveillance & #Research articles
Have a look
👇🏾
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.42.2200242
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.41.2200316
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.40.2100703
RT @Eurosurveillanc: Check out this week's issue
#SARSCoV2 #Omicron #COVID19 #vaccination #CovidVaccine #BA5
#diphtheria #outbreaks
#dengue #DengueFever #mosquitoes #vectorborne
#ColistinResistance #Ecoli #AntimicrobialResistance #AMR #OneHealth
#JustPublished: an EMA overview of characteristics of #COVID19vaccines authorised in the 🇪🇺.
These include:
➡️technology platforms
➡️virus strains
➡️use as primary vaccination or booster
➡️population
https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#covid-19-vaccines:-strains,-use-and-age-ranges-(new)-section
RT @UMCGlobalSafety: 📅 Join us next week for #MedSafetyWeek!
🌐 82 countries will come together to encourage the reporting of suspected side effects from medicines. #ReportSideEffects to your national medicines regulator or your healthcare professional.
Get involved 👉 https://ow.ly/XEoc50LlhaJ
RT @EUScienceInnov: 🔵Too many men die each year of male reproductive cancers!
We cannot stand idly by and need to reverse this worrisome data.
💡This #Movember find out how #MissionCancer aims to achieve this 🎯 by supporting prevention, screening, and early detection!
RT @WHO_Europe: #Influenza could come back this cold season alongside #COVID19.
What should countries do to protect the most vulnerable and safeguard health systems?
Read our 2022/23 autumn & winter strategy for COVID-19 & other respiratory viruses.
👇
https://www.who.int/europe/publications/i/item/WHO-EURO-2022-5851-45616-65461
RT @EU_Health: COVID-19 vaccines approved in EU have proven to be safe & to protect against severe illness & death.
We're moving to a standard marketing authorisation for Vaxzevria (AstraZeneca), following @EMA_News' recommendation.
More: https://ec.europa.eu/health/documents/community-register/html/index_en.htm
RT @ECDC_Flu: Cover your mouth and nose when sneezing, stay home when sick, take #antivirals and #vaccinate - take these simple and easy steps to curb the #influenza infections with us!
Let's prevent #flu from spreading this season!
https://www.ecdc.europa.eu/en/news-events/flu-awareness-campaign-2022
#FluAwareness
RT @RWE4Decisions: Don't miss our 24 November Symposium on Policies & Partnerships, where Xavier Kurz (@EMA_News) will present the #DARWINEU 2022 deliverables.
See the full list of speakers here 👉 https://rwe4decisions.com/event/rwe4decisions-symposium-policies-partnerships/
RT @ECDC_Flu: Let's prevent #flu from spreading this season!
Take the simple preventive steps for your own sake, but also to keep the vulnerable - elderly, frail, those with lowered immune system and pregnant women - safe and healthy.
Learn more: https://www.ecdc.europa.eu/en/news-events/flu-awareness-campaign-2022
#FluAwareness
#JustPublished: an EMA overview of characteristics of #COVID19vaccines authorised in the 🇪🇺.
These include:
➡️technology platforms
➡️virus strains
➡️use as primary vaccination or booster
➡️population
https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#covid-19-vaccines:-strains,-use-and-age-ranges-(new)-section
At its November meeting, our #safety committee, the #PRAC, recommended the addition of heavy menstrual bleeding as a side effect of the mRNA #COVID19 vaccines.
Most cases reviewed were non-serious and temporary.
Read the highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-24-27-october-2022
🧵
RT @EU_HaDEA: Thinking of applying for the #EU4Health calls?
Missed last week's info session?
📊Check out the presentations
🔴Listen to the recording
RT @EatrisEric: .@EMA_News is launching a pilot for academic sponsors & non-profits developing #AdvancedTherapy medicinal products. These medicines are based on genes, tissues or cells & might offer ground-breaking treatment options to #patients.
RT @ACCELERATE_cure: 📢The 10th Paediatric Strategy Forum for DNA Damage Repair Pathway Inhibitors has now begun at @EMA_News!
➡️Stay tuned for the summary and manuscript addressing the challenges and documenting the conclusions of the meeting.
RT @EU_Health: We are stepping up actions on air quality, incl. by aligning the EU’s air quality standards more closely with the @WHO recommendations
The #EUCancerPlan as part of the #HealthUnion reinforces cancer prevention by reducing air, water & soil pollution.
▶ https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union/cancer-plan-europe_en
RT @Eurosurveillanc: This week’s issue features an editorial by @EMA_News Emer Cooke on how to prepare #Europe for future health threats and crises by ensuring safe and effective medicines and medical devices.
⬇️
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.42.2200798
RT @Eurosurveillanc: This week’s 𝘌𝘶𝘳𝘰𝘴𝘶𝘳𝘷𝘦𝘪𝘭𝘭𝘢𝘯𝘤𝘦 issue is here
Check it out
👇🏾
https://bit.ly/EUS2742
#MonkeypoxVirus #MPX #MPXV #TickBorneDiseases #COVID19 #SARSCoV19
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.